Template:Main Page News

News - Thalidomide Molecular Mechanism shown in Zebrafish

PMID 27294876 | Nat Med. Thalidomide (and derivatives lenalidomide and pomalidomide) are treatments for hematologic malignancies, multiple myeloma (MM) and del(5q) myelodysplastic syndrome (MDS). Cereblon (CRBN) is the primary target for both the anticancer and teratogenic effects, and it promotes the maturation of CD147 (also known as Basigin) a member of the immunoglobulin superfamily). Zebrafish knockdown of CD147 was shown to match the teratogenic effects of thalidomide exposure. Links: Abnormal Development - Thalidomide | Zebrafish Development

Older News Articles - Human pancreas stem cells show glycemic control in mice | Oral contraceptive no risk of major birth defects | Maternal Malaria Neurovascular Development Effects | Oocyte/Spermatozoa fate decision Rubella eliminated in the Americas | Three-person embryos | 2014 Nobel Prize in Medicine - Neural Development | Hippocampus Development | WHO - Trends in Maternal Mortality 1990 to 2013 - Statistics - Maternal Mortality | WHO polio - Polio Virus | Trisomy 21 - Genome-wide Effects